The Article 4 Trap That Kills HMO Deals After Completion

What Article 4 Actually Does (And Why Most Investors Find Out Too Late)

Article 4 Directions are made by local planning authorities under the Town and Country Planning (General Permitted Development) (England) Order 2015. In plain English: they strip away your permitted development rights in a defined geographic area.

Normally, converting a standard dwelling (Use Class C3) into a small HMO of up to six occupants (Use Class C4) is permitted development. No planning application needed. You buy, you convert, you let.

Under an Article 4 Direction, that automatic right disappears. You need a full, discretionary planning application — and the council can refuse it. Often does, especially in areas where HMO saturation is already a political issue.

Here's what makes this genuinely dangerous: Article 4 Directions apply to the land, not the owner. Buying the property after the Direction was made doesn't give you any protection. The Direction doesn't appear on the title deeds in any obvious way. Your solicitor may not flag it unless they're specifically instructed to check. And plenty of vendors — especially those selling to inexperienced investors — either don't know or don't mention it.

The Cities Where This Trap Is Waiting for You Right Now

Quartico's April 2026 analysis described Article 4 as 'the single biggest regulatory trap for new HMO investors' — and the geography of affected areas makes that assessment hard to argue with.

Nottingham has Article 4 coverage across most of its student-heavy areas. Liverpool, Leeds, Sheffield, Birmingham — all have significant Article 4 zones. Most London boroughs have implemented Directions covering large swathes of inner-city residential streets. These aren't fringe locations. These are the cities where new HMO investors typically start looking, precisely because student demand and rental yields look attractive on paper.

That's the trap in its purest form. The cities with the most obvious HMO demand are often the same cities with the most aggressive Article 4 coverage.

HMOsales.com noted in their 2025-2026 market commentary that HMO growth is now concentrating in areas without Article 4 restrictions — places like Droylsden, Denton, and Stockport in East Manchester, where permitted development rights remain intact. That's not a coincidence. Experienced investors have quietly moved to unrestricted areas while newer investors keep chasing the obvious postcodes.

Sheffield is worth singling out. The council has extended Article 4 coverage multiple times since 2012. What was a restricted zone five years ago is now a much larger restricted zone. Directions can expand. An area that was fine when you started your search may not be fine by the time you complete.

The Mechanics of Getting Refused — And What Refusal Actually Costs

Say you buy a three-bedroom terrace in a Nottingham Article 4 zone. You paid £185,000, budgeted £25,000 for conversion, and modelled a yield of around 9% as a five-bed HMO. Then you apply for planning permission.

The council looks at HMO density in that street. If it's already above their threshold — Nottingham City Council has used a 10% threshold as a guideline in certain areas, meaning no more than one in ten properties on a street should be an HMO — your application is likely refused. You appeal. Appeals take months and cost money. You might lose anyway.

Now you're sitting on a property you can't convert to its intended use, with bridging finance or a development loan ticking, and your exit strategy has collapsed.

I want to be specific about the financial exposure here, because investors often underestimate it. Bridging finance at typical 2025-2026 rates runs between 0.75% and 1.1% per month. A six-month planning battle on a £185,000 loan at 0.9% per month is roughly £10,000 in interest alone — before legal fees, before the planning consultant, before any abortive conversion costs. That's before you've earned a single pound of rental income.

And if you ultimately can't get permission? You're selling a house you bought as an HMO investment, probably to someone who wants it as a family home, probably at a price that doesn't reflect your acquisition costs. The loss is real and it's unrecoverable.

Consider consulting a qualified solicitor before any acquisition in a potentially restricted area — they can commission a local land charges search and a planning history check that will surface Article 4 status. This is not optional due diligence. It's the minimum.

How Data-Led Searching Changes the Equation Before You Spend a Pound

The frustrating thing is that Article 4 status is public information. Every Direction is formally published by the local planning authority. The problem isn't that the data doesn't exist — it's that it's scattered across dozens of council websites in inconsistent formats, often buried in planning policy documents from years ago.

Tools like HMO Checker aggregate Article 4 coverage, HMO density data, and planning likelihood scores at postcode level. That's useful. But the problem with point-in-time tools is that Article 4 Directions change — they get extended, amended, and occasionally introduced to areas that were previously unrestricted. Static data goes stale.

This is exactly why I think a constantly updated HMO database matters more than most investors realise. At [ZARSK](https://zarsk.co.uk), the database is built specifically around this problem. You can search live HMO opportunities across the UK and surface Article 4 status as part of the property-level data — before you've arranged a viewing, before you've spoken to an agent, before you've committed a single pound to due diligence.

That changes the workflow fundamentally. Instead of finding a property you like and then checking whether it's in a restricted zone, you start with the restriction data and only look at properties that clear that filter. It's the difference between buying and hoping versus buying with a clear regulatory picture.

For investors who already hold a portfolio — whether buy-to-let or existing HMOs — the financing question is often just as pressing as the search question. Freeing up equity in an existing portfolio to fund new acquisitions is genuinely difficult. High street lenders are conservative on HMO valuations and refinancing timelines. ZARSK's regulated finance partners work specifically with HMO investors on exactly this problem, including portfolio refinancing and equity release where standard lenders won't move. Worth knowing that route exists before you assume the capital isn't available. You can find out more at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property).

The Pre-Purchase Checklist That Actually Protects You

Before you make an offer on any property you're targeting as an HMO, run through these five checks in this order.

First: confirm the current Use Class. Is it C3 (dwelling) or already C4 (small HMO)? An existing C4 property in an Article 4 zone is a fundamentally different proposition — the use class is already established, and you're not triggering a change of use.

Second: check Article 4 Direction coverage at postcode level. Don't rely on an agent's assurance. Look it up directly on the local planning authority's website, or use a data platform that aggregates this. If the council's planning portal is unclear, call the planning department directly and ask for written confirmation.

Third: check HMO density on that specific street. Even if you can apply for planning permission, high local density is the most common reason for refusal. Some councils publish their HMO licensing registers — cross-reference these.

Fourth: check whether an Article 4 Direction is proposed but not yet in force. Councils give notice before implementing a Direction, often 12 months. Buying in a proposed Article 4 area is a bet that you'll complete conversion before the Direction takes effect. That's a risk most investors shouldn't take.

Fifth: check the HMO licensing requirements separately. Article 4 is a planning issue. Mandatory HMO licensing (for properties with five or more occupants) is a separate regime. Additional licensing schemes — where councils require licences for smaller HMOs — operate independently again. You can clear the Article 4 hurdle and still face a licensing refusal. Both need checking.

Article 4 isn't going away. If anything, the political pressure on councils to manage HMO density means more Directions, covering more areas, over the next five years. The investors who build sustainable HMO portfolios are the ones who treat regulatory data as the first filter, not an afterthought. The ones who get burned are the ones who fall in love with a property and check the planning situation afterwards. That sequence — property first, data second — is how you end up owning a house you can't legally use for its intended purpose. Reverse it.